This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Concordia University, Marquette University. Active years: 2020.
Company Filing History:
1 out of 28 
1 out of 71 
Years Active: 2020
Title: The Innovations of William A. Donaldson
Introduction
William A. Donaldson is a notable inventor based in Milwaukee, Wisconsin. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the estrogen receptor beta isoform. His work has implications for treating various diseases associated with estrogen receptor activity.
Latest Patents
Donaldson holds a patent for "Substituted (4'-hydroxyphenyl)cyclohexane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform." This patent discloses substituted (4'-hydroxylphenyl)cycloalkane compounds that can be formulated as pharmaceutical compositions. These compounds are intended for administration in the treatment of diseases related to estrogen receptor activity, including proliferative and psychiatric disorders.
Career Highlights
Throughout his career, Donaldson has been associated with prominent educational institutions such as Marquette University and Concordia University. His work in these institutions has allowed him to advance his research and collaborate with other professionals in the field.
Collaborations
Some of his notable coworkers include Daniel S. Sem and Terrence S. Neumann. Their collaboration has likely contributed to the development and refinement of his innovative ideas and patents.
Conclusion
William A. Donaldson's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence the treatment of diseases associated with estrogen receptor activity.